Vascepa

Active Ingredient(s): Icosapent Ethyl
FDA Approved: * July 26, 2012
Pharm Company: * AMARIN PHARMS
Category: Diet / Weight Loss

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Vascepa Overview

Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia[2] and hypertriglyceridemia.[1] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150mg/dL.[3] It is made from the omega-3 fatty acid eicosapentaenoic acid (EPA).[3] The US Food and Drug Administration (FDA) granted the approval of icosapent ethyl...

Read more Vascepa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

Recent Vascepa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Icosapent Ethyl
  • Capsule: 1g, 1gm, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vascepa: (4 results)

Sorted by National Drug Code
  • 52937-001 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.
  • 52937-003 Vascepa 500 mg Oral Capsule by Amarin Pharma Inc.
  • 52937-101 Vascepa 1000 mg Oral Capsule by Amarin Pharma Inc.
  • 63629-8247 Vascepa 1000 mg Oral Capsule by Bryant Ranch Prepack

Other drugs which contain Icosapent Ethyl or a similar ingredient: (1 result)